Mergers & Acquisitions
Investors Still Support Pfizer CEO After Failed Merger With Allergan
The company called off the acquisition of Allergan after the U.S. Treasury issued the rule preventing the deal. Nevertheless, Chief Executive Officer Ian Read still has the investors support.
Pfizer and Allergan May Have to Call-Off Their $160 Billion Merger
Pfizer and Allergan will have to scrap the merger deal following the new regulation from Treasury Department to stop the U.S. company moving overseas.
China’s Anbang Acquired Allianz’s South Korea Operations After Dropping Its Bid for Starwood Hotels
Anbang Insurance is acquiring Allianz’s operations in South Korea after dropping its offer to buy Starwood hotels. The deal is waiting for approval from South Korea’s financial regulator.
Pfizer to end merger deal with Allergan as new rules frighten corporate inversions
Pfizer, a US-based drug company, is said to dismiss its merger deal with Allergan. The US drugmaker wants to quit from the $160 billion merger deal since Washington authorities set new rules, making corporate inversions harder.